American College of Clinical Pharmacy
      Search      Cart
         

Sun-31 - MeRIT Project: Patient Satisfaction with Enhanced Patient Care Services within a Clinically Integrated Network of Community Pharmacies

Scientific Poster Session II - MeRIT Primer Participants (Proposed Research)

2023 MeRIT Primer Participants – Proposed Research
  Sunday, November 12, 2023
  12:45 PM–02:15 PM

Abstract

Introduction: Community pharmacies in clinically integrated networks (CIN) provide a novel patient-centered community-based care model. CPESN USA is the predominant CIN for independently owned community pharmacies in America. CPESN USA has active payer programs through which pharmacies are reimbursed for services including social determinant of health screenings, disease state management, and medication management. While it is known that these services benefit patients, there are no studies that have quantified 1) patient acceptability of these services, or 2) general patient satisfaction with pharmacies in a CIN. Quantifying acceptability of services and patient satisfaction is important for sustained integration of clinical services into community pharmacy practice.

Research Question or Hypothesis:

  1. To what extent do patients find receiving specific services through a CIN acceptable?
  2. How satisfied are patients with their overall care experience within a CIN?

Study Design: Quantitative, cross-sectional survey of patients at community pharmacies within one CIN.

Methods: Subjects will be Medicaid beneficiaries who received pharmacy patient care services through a payer program. We will use a two-step random sampling strategy including approximately 20 CIN pharmacies and approximately 30 patients at each. Survey items were informed by the Theoretical Framework of Acceptability and community pharmacy services literature and will be further refined through pilot testing. Items will include multiple-choice, Likert scale, and open-ended questions. The survey will be deployed electronically. Descriptive statistics will be used to characterize all data. Mean acceptability ratings will be compared across services using t-tests, with a p-value of 0.05 considered significant. Content analysis of responses to open-ended survey items will be performed. This research will be submitted for review to the University’s Institutional Review Board.

Results: Research in progress.

Conclusion: Research in progress.

Presenting Author

Sophia Herbert PharmD
University of Pittsburgh School of Pharmacy

Authors

Evan Rabinowitz PharmD Candidate
University of Pittsburgh

Kim Coley Pharm.D.
University of Pittsburgh School of Pharmacy

Laura DeMarse PharmD Candidate
University of Pittsburgh

Kayleigh Walker PharmD Candidate
University of Pittsburgh

Margie Snyder PharmD, MPH, FCCP, FAPhA
Purdue University College of Pharmacy